1. vulnerable populations such as pregnant patients, children, individuals with severe physical or mental disabilities who cannot provide meaningful consent. 2. active malignancy requiring treatment within the last five years. 3. major physical trauma in the last 3 months, including motor vehicle accidents, assaults, mechanical falls with sequelae of significant bleeding or craniofacial bruising, and surgeries. 4. patients with persistent symptoms due to any of the following chronic comorbidities such as active tuberculosis or cystic fibrosis, chronic respiratory disease including chronic obstructive pulmonary disease or pulmonary fibrosis requiring baseline home oxygen \> 5 l o2/min, history of unstable angina or a heart attack during the last 12 months, pulmonary hypertension, hepatic impairment, chronic kidney disease, uncontrolled diabetes, substance abuse, severe osteoarthritis, hiv, migraine disorder, fibromyalgia, dementia, connective tissue disorders, and endocrine disorders. 5. depression as screened by positive patient health questionnaire (phq2) and confirmed as moderate or higher severity on phq9 (see appendix 11.5). of note, subjects found to have moderate or higher on phq-9 will be referred for appropriate outpatient psychiatric evaluation and intervention for their depression. 6. vital sign abnormalities: temperature ≥ 38 °c, temperature \< 35 °c; systolic blood pressure (sbp) \< 90 mmhg, sbp ≥ 170 mmhg; diastolic blood pressure (dbp) \< 50 mmhg, dbp ≥ 100 mmhg; heart rate (hr) \< 50 beats per minute (bpm), hr ≥ 120 bpm. 7. lab abnormalities: wbc ≥ 12,000 /μl, creatinine ≥ 1.5 mg/dl, ast ≥ 100 iu/l, and/or alt ≥ 100 iu/i 8. patients who require rolling walker or wheelchair or higher level of assistance for ambulation.

1. vulnerable populations such as pregnant patients, children, individuals with severe physical or mental disabilities who cannot provide meaningful consent. 2. active malignancy requiring treatment within the last five years. 3. major physical trauma in the last 3 months, including motor vehicle accidents, assaults, mechanical falls with sequelae of significant bleeding or craniofacial bruising, and surgeries. 4. patients with persistent symptoms due to any of the following chronic comorbidities such as active tuberculosis or cystic fibrosis, chronic respiratory disease including chronic obstructive pulmonary disease or pulmonary fibrosis requiring baseline home oxygen \> 5 l o2/min, history of unstable angina or a heart attack during the last 12 months, pulmonary hypertension, hepatic impairment, chronic kidney disease, uncontrolled diabetes, substance abuse, severe osteoarthritis, hiv, migraine disorder, fibromyalgia, dementia, connective tissue disorders, and endocrine disorders. 5. depression as screened by positive patient health questionnaire (phq2) and confirmed as moderate or higher severity on phq9 (see appendix 11.5). of note, subjects found to have moderate or higher on phq-9 will be referred for appropriate outpatient psychiatric evaluation and intervention for their depression. 6. vital sign abnormalities: temperature ≥ 38 °c, temperature \< 35 °c; systolic blood pressure (sbp) \< 90 mmhg, sbp ≥ 170 mmhg; diastolic blood pressure (dbp) \< 50 mmhg, dbp ≥ 100 mmhg; heart rate (hr) \< 50 beats per minute (bpm), hr ≥ 120 bpm. 7. lab abnormalities: wbc ≥ 12,000 /μl, creatinine ≥ 1.5 mg/dl, ast ≥ 100 iu/l, and/or alt ≥ 100 iu/i 8. patients who require rolling walker or wheelchair or higher level of assistance for ambulation.

vulnerable populations such as pregnant patients, children, individuals with severe physical or mental disabilities who cannot provide meaningful consent. active malignancy requiring treatment within the last five years. major physical trauma in the last 3 months, including motor vehicle accidents, assaults, mechanical falls with sequelae of significant bleeding or craniofacial bruising, and surgeries. patients with persistent symptoms due to any of the following chronic comorbidities such as active tuberculosis or cystic fibrosis, chronic respiratory disease including chronic obstructive pulmonary disease or pulmonary fibrosis requiring baseline home oxygen > 5 l o2/min, history of unstable angina or a heart attack during the last 12 months, pulmonary hypertension, hepatic impairment, chronic kidney disease, uncontrolled diabetes, substance abuse, severe osteoarthritis, hiv, migraine disorder, fibromyalgia, dementia, connective tissue disorders, and endocrine disorders. depression as screened by positive patient health questionnaire (phq2) and confirmed as moderate or higher severity on phq9 (see appendix 11.5). of note, subjects found to have moderate or higher on phq-9 will be referred for appropriate outpatient psychiatric evaluation and intervention for their depression. vital sign abnormalities: temperature ≥ 38 °c, temperature < 35 °c; systolic blood pressure (sbp) < 90 mmhg, sbp ≥ 170 mmhg; diastolic blood pressure (dbp) < 50 mmhg, dbp ≥ 100 mmhg; heart rate (hr) < 50 beats per minute (bpm), hr ≥ 120 bpm. lab abnormalities: wbc ≥ 12,000 /μl, creatinine ≥ 1.5 mg/dl, ast ≥ 100 iu/l, and/or alt ≥ 100 iu/i patients who require rolling walker or wheelchair or higher level of assistance for ambulation.

vulnerable populations such as pregnant patients, children, individuals with severe physical or mental disabilities who cannot provide meaningful consent. active malignancy requiring treatment within the last five years. major physical trauma in the last 3 months, including motor vehicle accidents, assaults, mechanical falls with sequelae of significant bleeding or craniofacial bruising, and surgeries. patients with persistent symptoms due to any of the following chronic comorbidities such as active tuberculosis or cystic fibrosis, chronic respiratory disease including chronic obstructive pulmonary disease or pulmonary fibrosis requiring baseline home oxygen > 5 l o2/min, history of unstable angina or a heart attack during the last 12 months, pulmonary hypertension, hepatic impairment, chronic kidney disease, uncontrolled diabetes, substance abuse, severe osteoarthritis, hiv, migraine disorder, fibromyalgia, dementia, connective tissue disorders, and endocrine disorders. depression as screened by positive patient health questionnaire (phq2) and confirmed as moderate or higher severity on phq9 (see appendix 11.5). of note, subjects found to have moderate or higher on phq-9 will be referred for appropriate outpatient psychiatric evaluation and intervention for their depression. vital sign abnormalities: temperature ≥ 38 °c, temperature < 35 °c; systolic blood pressure (sbp) < 90 mmhg, sbp ≥ 170 mmhg; diastolic blood pressure (dbp) < 50 mmhg, dbp ≥ 100 mmhg; heart rate (hr) < 50 beats per minute (bpm), hr ≥ 120 bpm. lab abnormalities: wbc ≥ 12,000 /μl, creatinine ≥ 1.5 mg/dl, ast ≥ 100 iu/l, and/or alt ≥ 100 iu/i patients who require rolling walker or wheelchair or higher level of assistance for ambulation.

1. vulnerable populations such as pregnant patients, children, individuals with severe physical or mental disabilities who cannot provide meaningful consent. 2. active malignancy requiring treatment within the last five years. 3. major physical trauma in the last 3 months, including motor vehicle accidents, assaults, mechanical falls with sequelae of significant bleeding or craniofacial bruising, and surgeries. 4. patients with persistent symptoms due to any of the following chronic comorbidities such as active tuberculosis or cystic fibrosis, chronic respiratory disease including chronic obstructive pulmonary disease or pulmonary fibrosis requiring baseline home oxygen > 5 l o2/min, history of unstable angina or a heart attack during the last 12 months, pulmonary hypertension, hepatic impairment, chronic kidney disease, uncontrolled diabetes, substance abuse, severe osteoarthritis, hiv, migraine disorder, fibromyalgia, dementia, connective tissue disorders, and endocrine disorders. 5. depression as screened by positive patient health questionnaire (phq2) and confirmed as moderate or higher severity on phq9 (see appendix 11.5). of note, subjects found to have moderate or higher on phq-9 will be referred for appropriate outpatient psychiatric evaluation and intervention for their depression. 6. vital sign abnormalities: temperature ≥ 38 °c, temperature < 35 °c; systolic blood pressure (sbp) < 90 mmhg, sbp ≥ 170 mmhg; diastolic blood pressure (dbp) < 50 mmhg, dbp ≥ 100 mmhg; heart rate (hr) < 50 beats per minute (bpm), hr ≥ 120 bpm. 7. lab abnormalities: wbc ≥ 12,000 /μl, creatinine ≥ 1.5 mg/dl, ast ≥ 100 iu/l, and/or alt ≥ 100 iu/i 8. patients who require rolling walker or wheelchair or higher level of assistance for ambulation.

1. vulnerable populations such as pregnant patients, children, individuals with severe physical or mental disabilities who cannot provide meaningful consent. 2. active malignancy requiring treatment within the last five years. 3. major physical trauma in the last 3 months, including motor vehicle accidents, assaults, mechanical falls with sequelae of significant bleeding or craniofacial bruising, and surgeries. 4. patients with persistent symptoms due to any of the following chronic comorbidities such as active tuberculosis or cystic fibrosis, chronic respiratory disease including chronic obstructive pulmonary disease or pulmonary fibrosis requiring baseline home oxygen > 5 l o2/min, history of unstable angina or a heart attack during the last 12 months, pulmonary hypertension, hepatic impairment, chronic kidney disease, uncontrolled diabetes, substance abuse, severe osteoarthritis, hiv, migraine disorder, fibromyalgia, dementia, connective tissue disorders, and endocrine disorders. 5. depression as screened by positive patient health questionnaire (phq2) and confirmed as moderate or higher severity on phq9 (see appendix 11.5). of note, subjects found to have moderate or higher on phq-9 will be referred for appropriate outpatient psychiatric evaluation and intervention for their depression. 6. vital sign abnormalities: temperature ≥ 38 °c, temperature < 35 °c; systolic blood pressure (sbp) < 90 mmhg, sbp ≥ 170 mmhg; diastolic blood pressure (dbp) < 50 mmhg, dbp ≥ 100 mmhg; heart rate (hr) < 50 beats per minute (bpm), hr ≥ 120 bpm. 7. lab abnormalities: wbc ≥ 12,000 /μl, creatinine ≥ 1.5 mg/dl, ast ≥ 100 iu/l, and/or alt ≥ 100 iu/i 8. patients who require rolling walker or wheelchair or higher level of assistance for ambulation.